Subscribe in a reader

Cambridge MedChem Consulting

Open Targets Platform: rebuilt, redesigned, reimagined

The Open Targets Platform has been updated.

  • The new design of the Platform improves user experience and access to information. It has been reimagined to facilitate the building of new therapeutic hypotheses;
  • New features include data on binary molecular interactions, and black box warnings;
  • A complete refactoring of the codebase enables rapid development and new deployment strategies.